Harpoon Therapeutics, Inc. Business Operations Contracts & Agreements
10 Contracts & Agreements
- Collaboration Agreements (6 contracts)
- Development Agreements (4)
- Amendment No. 1 to Amended and Restated Discovery Collaboration and License Agreement by and between the Registrant and AbbVie, Inc., dated as of August 16, 2021 (Filed With SEC on November 10, 2021)
- Side Letter Amendment to Development and Option Agreement between the Registrant and AbbVie Biotechnology Ltd., dated April 15, 2020 (Filed With SEC on August 5, 2020)
- First Amendment to the Development and Option Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of April 21, 2020 (Filed With SEC on August 5, 2020)
- Development and Option Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of November 20, 2019 (Filed With SEC on March 12, 2020)
- Amended and Restated Discovery Collaboration and License Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of November 20, 2019 (Filed With SEC on March 12, 2020)
- First Amendment to the Discovery Collaboration and License Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of April 3, 2019 (Filed With SEC on May 9, 2019)
- Amendment to CHEF1 Collaboration and License Agreement and Development and Manufacturing Services Agreement between Registrant and AGC Biologics, Inc. (formerly known as CMC ICOS... (Filed With SEC on January 29, 2019)
- Development and Manufacturing Services Agreement between the Registrant and CMC ICOS Biologics, Inc., dated July 5, 2016 (Filed With SEC on December 27, 2018)
- CHEF1 Collaboration and License Agreement between the Registrant and CMC ICOS Biologics, Inc., dated October 26, 2015 (Filed With SEC on December 27, 2018)
- Discovery Collaboration and License Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of October 10, 2017 (Filed With SEC on December 27, 2018)
